Reduced accumulation of specific microRNAs in colorectal neoplasia.
By M. Michael, Susan M O' Connor, Nicholas G van Holst Pellekaan, Graeme P. Young, R. James. Molecular Cancer Research, 2003
1,715 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/5be20043c72560471655eba6f2a23329f5ea5f5e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Danish H Sayed
- Carlo Maria Croce
- Baohong Zhang
- George A. Calin
- Frank J. Slack
- Marilena V. Iorio
- V. Narry Kim
- M. Abdellatif
Citations in the corpus
- MicroRNA-cancer connection: the beginning of a new tale. (2006, background): “For example, effects of t(14;18)(q32;q21) or del13q14.”
- Identification of metastasis‐related microRNAs in hepatocellular carcinoma (2008, unknown): “0001 TNM Stage I 99 (41) 66 (50) 33 (30) II 87 (36) 34 (26) 53 (48) III 55 (23) 31 (24) 24 (22) 0.”
- Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. (2007, background): “Deregulated microRNA expression has been documented in diverse cancers including lymphoma (11–14), colorectal cancer (15), lung cancer (16), breast cancer (17), and glioblastoma (18, 19), and specific microRNAs have been shown to target genes which are critical regulators for the development of canc”
- Human MicroRNA Targets (2004, background): “Similarly, miR-143 and miR-145 are down-regulated at the adenomatous and cancer stages of colorectal neoplasia (Michael et al. 2003), and miR-155 is up-regulated in children with Burkitt lymphoma (Metzler et al. 2004).”